Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3443PDF: 2039HTML: 7572 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1875PDF: 760HTML: 425 -
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1402PDF: 486HTML: 18624Figure 1: 185Figure 2: 165Figure 3: 183Figure 4: 219Figure 5: 194 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2281PDF: 1665HTML: 544 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3256PDF: 1175HTML: 1684Untitled: 201Untitled: 190Untitled: 189 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2664PDF: 842HTML: 5374 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1792PDF: 1319HTML: 613 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3522PDF: 820HTML: 3022Figure 1a and 1b: 170Figure 2: 178Figure 3: 197Figure 4: 177Figure 5: 182Tables 1-5: 166 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5728PDF: 1565HTML: 1661Untitled: 257 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2499PDF: 1221HTML: 1052 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3143PDF: 1052HTML: 3191 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1466PDF: 723HTML: 1186Untitled: 202Untitled: 166Untitled: 156Untitled: 169Untitled: 179 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1466HTML: 641PDF: 876 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2502PDF: 1637HTML: 698 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2334PDF: 919HTML: 2014Fig 1 Rossi: 220 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1159PDF: 850HTML: 205 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3745PDF: 1338HTML: 2162Fig.1: 235Fig. 2: 230 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2691PDF: 1673HTML: 2450Table1: 212 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3132PDF: 1644HTML: 365 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2681PDF: 1004HTML: 15132 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1523PDF: 1370HTML: 112 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1023PDF: 556HTML: 741 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1248PDF: 880HTML: 113 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1951HTML: 1648PDF: 1152 -







